Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Sutter

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Drug Design, Development and Therapy|December 24, 2016
Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapyTimothy E Albertson, Samuel W Bullick, Michael Schivo, et al.
Disaster Medicine and Public Health Preparedness|October 16, 2018
Contingency Medical Countermeasures for Mass Nerve-Agent Exposure: Use of Pharmaceutical Alternatives to Community Stockpiled AntidotesMichael D Schwartz, Mark E Sutter, Derek Eisnor, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 15, 2011
Case series of selenium toxicity from a nutritional supplementBarrak M Aldosary, Mark E Sutter, Michael Schwartz, et al.
International Journal of Emergency Medicine|October 14, 2011
Gastrointestinal decontamination in the acutely poisoned patientTimothy E Albertson, Kelly P Owen, Mark E Sutter, et al.
FP Essentials|February 17, 2016
The Changing Drug Culture: Emerging Drugs of Abuse and Legal HighsTimothy E Albertson, James A Chenoweth, Daniel K Colby, et al.
Expert Opinion on Investigational Drugs|December 9, 2016
Muscarinic antagonists in early stage clinical development for the treatment of asthmaTimothy E Albertson, James A Chenoweth, Jason Y Adams, et al.
FP Essentials|February 17, 2016
The Changing Drug Culture: Use and Misuse of Appearance- and Performance-Enhancing DrugsTimothy E Albertson, James A Chenoweth, Daniel K Colby, et al.
Clinical and Experimental Emergency Medicine|February 8, 2017
Urine metabolomic analysis to detect metabolites associated with the development of contrast induced nephropathyDeborah B Diercks, Kelly P Owen, Jeffrey A Kline, et al.
Clinical Reviews in Allergy & Immunology|May 8, 2013
Volatile substance misuse: an updated review of toxicity and treatmentJonathan B Ford, Mark E Sutter, Kelly P Owen, et al.
International Journal of Emergency Medicine|September 1, 2011
Fatal myocardial infarction associated with intravenous N-acetylcysteine errorAndrew R Elms, Kelly P Owen, Timothy E Albertson, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Drug Design, Development and Therapy|December 24, 2016
Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapyTimothy E Albertson, Samuel W Bullick, Michael Schivo, et al.
Disaster Medicine and Public Health Preparedness|October 16, 2018
Contingency Medical Countermeasures for Mass Nerve-Agent Exposure: Use of Pharmaceutical Alternatives to Community Stockpiled AntidotesMichael D Schwartz, Mark E Sutter, Derek Eisnor, et al.
Clinical Toxicology (Philadelphia, Pa.)|December 15, 2011
Case series of selenium toxicity from a nutritional supplementBarrak M Aldosary, Mark E Sutter, Michael Schwartz, et al.
International Journal of Emergency Medicine|October 14, 2011
Gastrointestinal decontamination in the acutely poisoned patientTimothy E Albertson, Kelly P Owen, Mark E Sutter, et al.
FP Essentials|February 17, 2016
The Changing Drug Culture: Emerging Drugs of Abuse and Legal HighsTimothy E Albertson, James A Chenoweth, Daniel K Colby, et al.
Expert Opinion on Investigational Drugs|December 9, 2016
Muscarinic antagonists in early stage clinical development for the treatment of asthmaTimothy E Albertson, James A Chenoweth, Jason Y Adams, et al.
FP Essentials|February 17, 2016
The Changing Drug Culture: Use and Misuse of Appearance- and Performance-Enhancing DrugsTimothy E Albertson, James A Chenoweth, Daniel K Colby, et al.
Clinical and Experimental Emergency Medicine|February 8, 2017
Urine metabolomic analysis to detect metabolites associated with the development of contrast induced nephropathyDeborah B Diercks, Kelly P Owen, Jeffrey A Kline, et al.
Clinical Reviews in Allergy & Immunology|May 8, 2013
Volatile substance misuse: an updated review of toxicity and treatmentJonathan B Ford, Mark E Sutter, Kelly P Owen, et al.
International Journal of Emergency Medicine|September 1, 2011
Fatal myocardial infarction associated with intravenous N-acetylcysteine errorAndrew R Elms, Kelly P Owen, Timothy E Albertson, et al.
Pageof 5